Perspective Therapeutics (CATX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $68.0 million.
- Perspective Therapeutics' Other Gross PP&E Adjustments rose 5593.97% to $68.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.0 million, marking a year-over-year increase of 5593.97%. This contributed to the annual value of $56.6 million for FY2024, which is 182010.85% up from last year.
- As of Q3 2025, Perspective Therapeutics' Other Gross PP&E Adjustments stood at $68.0 million, which was up 5593.97% from $65.3 million recorded in Q2 2025.
- Perspective Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $68.0 million during Q3 2025, with a 5-year trough of $296000.0 in Q4 2022.
- In the last 5 years, Perspective Therapeutics' Other Gross PP&E Adjustments had a median value of $13.8 million in 2023 and averaged $22.7 million.
- Per our database at Business Quant, Perspective Therapeutics' Other Gross PP&E Adjustments tumbled by 9659.69% in 2022 and then skyrocketed by 182010.85% in 2024.
- Perspective Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $8.7 million in 2021, then tumbled by 96.6% to $296000.0 in 2022, then skyrocketed by 896.28% to $2.9 million in 2023, then surged by 1820.11% to $56.6 million in 2024, then grew by 20.11% to $68.0 million in 2025.
- Its Other Gross PP&E Adjustments was $68.0 million in Q3 2025, compared to $65.3 million in Q2 2025 and $62.9 million in Q1 2025.